# A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol (0653-050)(COMPLETED)

> **NCT00652301** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 40 (actual)

## Conditions studied

- Cholesterol

## Interventions

- **DRUG:** ezetimibe
- **DRUG:** Comparator: Placebo (unspecified)
- **DRUG:** simvastatin

## Key facts

- **NCT ID:** NCT00652301
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2004-04
- **Final completion:** 2004-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00652301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00652301, "A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol (0653-050)(COMPLETED)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00652301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*